Weiss Multi-Strategy Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-391,633	Closed	-$71.9M	–	868
2021 Q2	$71.9M	Buy	391,633 +165,882	+73%	+$28.5M	1.58%	2
2021 Q1	$34.5M	Buy	225,751 +87,084	+63%	+$13.5M	0.76%	11
2020 Q4	$21.7M	Buy	138,667 +129,149	+1,357%	+$16.6M	0.42%	63
2020 Q3	$1.09M	Sell	9,518 -2,508	-21%	-$271K	0.03%	419
2020 Q2	$1.35M	Buy	12,026 +2,159	+22%	+$229K	0.04%	378
2020 Q1	$886K	Buy	9,867 +4,579	+87%	+$449K	0.03%	312
2019 Q4	$572K	Buy	5,288 +288	+6%	+$30.8K	0.01%	530
2019 Q3	$490K	Hold	5,000	–	–	0.01%	494
2019 Q2	$655K	Buy	5,000 +3,000	+150%	+$387K	0.02%	407
2019 Q1	$270K	Sell	2,000 -3,000	-60%	-$373K	0.01%	468
2018 Q4	$487K	Buy	+5,000	New	+$591K	0.02%	352
2015 Q4	–	Sell	-5,083	Closed	-$795K	–	471
2015 Q3	$795K	Buy	+5,083	New	+$927K	0.04%	282
2015 Q1	–	Sell	-5,000	Closed	-$925K	–	546
2014 Q4	$925K	Hold	5,000	–	–	0.03%	293
2014 Q3	$829K	Sell	5,000 -380	-7%	-$62.4K	0.02%	397
2014 Q2	$841K	Buy	5,380 +1,850	+52%	+$292K	0.02%	441
2014 Q1	$537K	Sell	3,530 -2,690	-43%	-$428K	0.01%	628
2013 Q4	$827K	Buy	6,220 +3,780	+155%	+$454K	0.02%	478
2013 Q3	$283K	Buy	+2,440	New	+$268K	0.01%	660

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ALXN Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 391,633 shares — an estimated $71.9M sold.

Weiss Multi-Strategy Advisers first reported a position in ALXN in Q3 2013 and held it in 18 quarters. The position peaked at $71.9M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Weiss Multi-Strategy Advisers reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 391,633 Alexion Pharmaceuticals shares in Q3 2021, an estimated $71.9M.
Weiss Multi-Strategy Advisers first reported a position in Alexion Pharmaceuticals in Q3 2013 and held it in 18 quarters.
Weiss Multi-Strategy Advisers's Alexion Pharmaceuticals position peaked at $71.9M in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.